Trademarkia Logo

Canada

C$
OJEMDA and Design
FORMALIZED

on 22 Apr 2024

Last Applicant/ Owned by

Day One Biopharmaceuticals, Inc.

1800 Sierra Point Parkway, Suite 200Brisbane, CA 94005

US

Serial Number

2322908 filed on 22nd Apr 2024

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

OJEMDA and Design

Trademark usage description

pharmaceutical preparations for human use for the treatment of cancer; pharmaceutical preparation for the prevention and treatment of cancer; pharmace Read More

Vienna Information


17 . 2 . 1

Precious stonesPierres précieuses

17 . 2 . 4

Other representations of precious stonesAutres représentations de pierres précieuses

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 26

Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées

25 . 7 . 1

Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés

25 . 7 . 8

Surfaces or backgrounds covered with other repeated geometrical figures or designsSurfaces ou fonds couverts d'autres figures ou motifs géométriques répétés

Classification Information


Class [005]
Pharmaceutical preparations for human use for the treatment of cancer; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system diseases and disorders; targeted pharmaceutical preparations for use in the field of cancer prevention and treatment; pharmaceutical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders


Classification kind code

12

Class [042]
Research, development, and product evaluation of pharmaceutical preparations for the prevention and treatment of cancer; laboratory analysis and research of drugs and pharmaceutical products; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; design, development, research, and testing of new products, namely, drugs and pharmaceuticals for the treatment and/or prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system diseases and disorders


Classification kind code

12

Class [044]
Medical information services; healthcare services; healthcare services, namely, providing cancer treatment information to physicians, health care professionals, and patients; medical information services, namely, providing information regarding viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system diseases and disorders


Classification kind code

12

Mark Details


Serial Number

2322908

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 135
on 17th Jan 2025
Amendment to Application
Submitted for opposition 287
on 2th May 2024
Pre-Assessment Letter Sent
Submitted for opposition 30
on 22nd Apr 2024
Filed
Submitted for opposition 1
on 22nd Apr 2024
Created
Submitted for opposition 31
on 22nd Apr 2024
Formalized